Three common asthma inhalers containing the drugs salmeterol or
formoterol may be causing four out of five U.S. asthma-related deaths per
year and should be taken off the market, researchers from Cornell and
Stanford universities have concluded after a search of medical literature.
They base these conclusions on a statistical analysis of 19 published trials
involving 33,826 patients. This so-called meta-analysis found that patients
who inhaled the long-acting beta-agonists salmeterol (trade names Serevent
and Advair, both made by GlaxoSmithKline) or formoterol (trade name
Foradil, made by Novartis Pharmaceuticals) were 3.5 times more likely to die
from asthma and 2.5 times more likely to be hospitalized (whether or not
death resulted), compared with those taking a placebo.
The reason, say the researchers, is because although these medications relieve
asthma symptoms, they also promote bronchial inflammation and sensitivity
Da fällt einem wirklich nichts mehr ein mit was die Pharmalobby zum Teil so durchkommt. Unglaublich
Vielen vielen Dank fürs teilen Macarmo ich hoffe das erreicht diejenigen im Forum die betroffen sind !